[1] Li Y, Reverter D. Molecular mechanisms of DUBs regulation in signaling and disease. Int J Mol Sci. 2021;22(3):986. https://doi.org/10.3390/ijms22030986. [2] Kaushal K, Antao AM, Kim KS, Ramakrishna S. Deubiquitinating enzymes in cancer stem cells: functions and targeted inhibition for cancer therapy. Drug Discov Today. 2018;23(12):1974-82. https://doi.org/10.1016/j.drudis.2018.05.035. [3] He M, Zhou Z, Shah AA, Zou H, Tao J, Chen Q, et al. The emerging role of deubiquitinating enzymes in genomic integrity, diseases, and therapeutics. Cell Biosci. 2016. https://doi.org/10.1186/s13578-016-0127-1. [4] Park J, Cho J, Song EJ. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment. Arch Pharm Res. 2020;43(11):1144-61. https://doi.org/10.1007/s12272-020-01281-8. [5] Todi SV, Paulson HL. Balancing act: deubiquitinating enzymes in the nervous system. Trends Neurosci. 2011;34(7):370-82. https://doi.org/10.1016/j.tins.2011.05.004. [6] Bello AI, Goswami R, Brown SL, Costanzo K, Shores T, Allan S, et al. Deubiquitinases in neurodegeneration. Cells. 2022;11(3):556. https://doi.org/10.3390/cells11030556. [7] Yun S, Kwak C, Lee S, Shin S, Oh C, Kim JS, et al. Binding of usp4 to cortactin enhances cell migration in hct116 human colon cancer cells. FASEB J. 2023. https://doi.org/10.1096/fj.202201337rrr. [8] Wei Y, Wei S, Lei Z, Zhang Y, Wu J, Huang G, et al. USP4 promotes proliferation and metastasis in human lung adenocarcinoma. Sci Rep. 2025. https://doi.org/10.1038/s41598-025-89377-3. [9] Wang Y, Zhou L, Lu J, Jiang B, Liu C, Guo J. USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target. Cancer Cell Int. 2020. https://doi.org/10.1186/s12935-020-01391-9. [10] Hu B, Zhang D, Zhao K, Wang Y, Pei L, Fu Q, et al. Spotlight on USP4: structure, function, and regulation. Front Cell Dev Biol. 2021. https://doi.org/10.3389/fcell.2021.595159. [11] Hsu FS, Lin WC, Kuo KL, Chiu YL, Hsu CH, Liao SM, et al. PR-619, a general inhibitor of deubiquitylating enzymes, diminishes cisplatin resistance in urothelial carcinoma cells through the suppression of c-Myc: an in vitro and in vivo study. Int J Mol Sci. 2021;22(21):11706. https://doi.org/10.3390/ijms222111706. [12] Cowell IG, Ling EM, Swan RL, Brooks MLW, Austin CA. The deubiquitinating enzyme inhibitor PR-619 is a potent DNA topoisomerase II poison. Mol Pharmacol. 2019;96(5):562-72. https://doi.org/10.1124/mol.119.117390. [13] Mao M, Xia Q, Zhan G, Bing H, Zhang C, Wang J, et al. Vialinin A alleviates oxidative stress and neuronal injuries after ischaemic stroke by accelerating Keap1 degradation through inhibiting USP4-mediated deubiquitination. Phytomedicine. 2024;124:155304. https://doi.org/10.1016/j.phymed.2023.155304. [14] Erkisa M, Sariman M, Geyik OG, Geyik C, Stanojkovic T, Ulukaya E. Natural products as a promising therapeutic strategy to target cancer stem cells. CMC. 2022;29(4):741-83. https://doi.org/10.2174/0929867328666210628131409. [15] Ji R, Zha X, Zhou S. Marine fungi: a prosperous source of novel bioactive natural products. CMC. 2025;32(5):992-1006. https://doi.org/10.2174/0109298673266304231015070956. [16] Verma VC, Kharwar RN, Strobel GA. Chemical and functional diversity of natural products from plant associated endophytic fungi. Nat Prod Commun. 2009;4(11):1511-32. [17] Xie C, Koshino H, Esumi Y, Takahashi S, Yoshikawa K, Abe N. Vialinin A, a novel 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenger from an edible mushroom in China. Biosci Biotechnol Biochem. 2005;69(12):2326-32. https://doi.org/10.1271/bbb.69.2326. [18] Bailly C. Anti-inflammatory and anticancer p-terphenyl derivatives from fungi of the genus Thelephora. Bioorg Med Chem. 2022;70:116935. https://doi.org/10.1016/j.bmc.2022.116935. [19] Rammohan A, Khasanov AF, Kopchuk DS, Gunasekar D, Zyryanov GV, Chupakhin ON. Assessment on facile Diels-Alder approach of α-pyrone and terpenoquinone for the expedient synthesis of various natural scaffolds. Nat Prod Bioprospect. 2022;12:12. https://doi.org/10.1007/s13659-022-00333-4. [20] Zhai YJ, Zhou ZZ, Gao LL, Li JN, Pescitelli G, Gao JM, et al. Ethylidene-tethered chromene-pyrone hybrids as potential plant-growth regulators from an endolichenic Phaeosphaeria species. J Agric Food Chem. 2023;71:4615-24. https://doi.org/10.1021/acs.jafc.2c08710. [21] Gao LL, Fang XT, Zhao SH, Hui CX, Huang WW, Gao YQ, et al. Naphthoquinone derivatives from the endophytic fungus Fusarium solani induce pancreatic cancer cells apoptosis via targeting EGFR-mediated PI3K/Akt pathway. J Agric Food Chem. 2024;72:26209-23. https://doi.org/10.1021/acs.jafc.4c08652. [22] Zhai YJ, Huo GM, Wei J, Lin LB, Zhang Q, Li JN, et al. Structures and absolute configurations of butenolide derivatives from the isopod-associated fungus Pidoplitchkoviella terricola. Phytochemistry. 2022;193:112981. https://doi.org/10.1016/j.phytochem.2021.112981. [23] Zhang DW, Liu JM, Chen RD, Zhang M, Yu LY, Wu J, et al. A new lactone derivative from plant endophytic fungus Periconia sp F-31. Zhongguo Zhong Yao Za Zhi. 2015;40(12):2349-51. [24] Chang HS, Lin CH, Chen YS, Wang HC, Chan HY, Hsieh SY, et al. Secondary metabolites of the endophytic fungus Lachnum abnorme from Ardisia cornudentata. Int J Mol Sci. 2016;17(9):1512. https://doi.org/10.3390/ijms17091512. [25] Tezuka Y, Huang Q, Kikuchi T, Nishi A, Tubaki K. Studies on the metabolites of mycoparasitic fungi. I. Metabolites of Cladobotryum varium. Chem Pharm Bull. 1994;42(12):2612-7. https://doi.org/10.1248/cpb.42.2612. [26] Savi DC, Noriler SA, Ponomareva LV, Rohr J, Glienke C, Shaaban KA, et al. Dihydroisocoumarins produced by Diaporthe cf. heveae LGMF1631 inhibiting citrus pathogens. Folia Microbiol. 2020;65(2):381-92. https://doi.org/10.1007/s12223-019-00746-8. [27] Khan B, Li Y, Wei W, Liu GY, Xiao C, He B, et al. Chemical investigation of endophytic Diaporthe unshiuensis YSP3 reveals new antibacterial and cytotoxic agents. J Fungi. 2023;9(2):136. https://doi.org/10.3390/jof9020136. |